| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V78546 | Alfacalcidol-d7 (1-hydroxycholecalciferol-d7; 1.alpha.-Hydroxyvitamin D3-d7) | Alfacalcidol-d7 is the deuterated form of Alfacalcidol. | |
|
V89109 | Butyrate-Vitamin D3 | 31316-20-8 | Butyrate-Vitamin D3 (Butyrate-Cholecalciferol) is a derivative of vitamin D3 in which one of the hydroxyl groups in the vitamin D3 molecule is replaced by a butyrate group. |
|
V77044 | Eldecalcitol-d6 (Eldecalcitol d6) | Eldecalcitol-d6 is a deuterated form of Eldecalcitol. | |
|
V109724 | Ercalcidiol-d9 | 1202355-80-3 | Icariol-d9 (25-hydroxyvitamin D2-d9) is a deuterated derivative of ircaliol. |
|
V2401 | Doxercalciferol (1α-Hydroxyvitamin D2) | 54573-75-0 | Doxercalciferol (1α-hydroxyvitamin D2; 1alpha-hydroxy VD2), a synthetic vitamin D2 analog, is a potent agonist/activator of VDR (Vitamin D receptor) with important biological activities. |
|
V2037 | Alfacalcidol (1-hydroxycholecalciferol) | 41294-56-8 | Alfacalcidol (1-hydroxycholecalciferol), an active metabolite of Vitamin D, is a potent and non-selective VDR activator medication that has been widely used in the treatment of osteoporosis. |
|
V41330 | Maxacalcitol-D6 | Maxacalcitol-D6 is the hexa-deuterated form (at the 26,27-dimethyl group) of Maxacalcitol which is a novel calcitriol analog without hypercalcemic side effects. | |
|
V1857 | Calcitriol (1,25-Dihydroxyvitamin D3) | 32222-06-3 | Calcitriol (RO215535, Topitriol; 1,25(OH)2D3)is the metabolically/hormonally active form of vitamin D and avitamin D receptor(VDR) agonist. |
|
V2435 | Calcifediol (25-hydroxy Vitamin D3) | 19356-17-3 | Calcifediol (also known as 25-hydroxyvitamin D3; 25-hydroxy VD3)is the major circulating metabolite of vitamin D3 in the blood and is the form that is tested inmedicine to determine vitamin D deficiency, namely, the test of 25-hydroxy vitamin D (calcifediol) levels to evaluate how much vitamin D is in the body. |